Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9358304 Methods of making DLL3 antibody drug conjugates

Patent 9358304 was granted and assigned to Stemcentrx, Inc. on June, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12084518 Trispecific binding proteins and methods of use
0
Edits on 8 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11976125 B cell maturation antigen binding proteins
0
Edits on 5 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 5 Dec, 2023
Edits made to:
Article (+164 characters)
Article

Patent abstract

Novel modulatators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.

Edits on 16 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 16 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09358304 Methods of making DLL3 antibody drug conjugates US Patent 9358304 Methods of making DLL3 antibody drug conjugates

Infobox
Patent Number
0935830400
Patent Number
935830400
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0935830400
Edits on 29 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
Stemcentrx, Inc.
0
Current Assignee
‌
Stemcentrx, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
093583040
Date of Patent
June 7, 2016
0
Patent Application Number
150059930
Date Filed
January 25, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=093583040
Patent Primary Examiner
‌
Christine J. Saoud
0
Edits on 5 Oct, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 5 Oct, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
Stemcentrx, Inc.
0
Current Assignee
‌
Stemcentrx, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
093583040
Date of Patent
June 7, 2016
0
Patent Application Number
150059930
Date Filed
January 25, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=093583040
Patent Primary Examiner
‌
Christine J. Saoud
0
Edits on 4 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 4 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09358304
Edits on 7 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 7 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09358304 Methods of making DLL3 antibody drug conjugates

Infobox
Is a
Patent
Patent
Patent applicant
‌
Stemcentrx, Inc.
Current assignee
‌
Stemcentrx, Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09358304
Date of patent
June 7, 2016
Patent application number
15005993
Date Filed
January 25, 2016
Patent primary examiner
‌
Christine J. Saoud

Find more entities like US Patent 9358304 Methods of making DLL3 antibody drug conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo